How Much Does Azstarys Cost?
The retail price of Azstarys, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), can vary significantly based on factors such as dosage, quantity, and the pharmacy chosen. Without insurance, a prescription for Azstarys can cost several hundred dollars. For example, a 30-day supply of 50.5 mg/10.3 mg tablets might range from approximately $400 to over $500 [1].
Can I Get Help Paying for Azstarys?
Several options may be available to reduce the out-of-pocket cost of Azstarys.
* Manufacturer Coupons and Savings Cards: The manufacturer of Azstarys, Corium, offers a savings card program for eligible commercially insured patients. This program can lower the cost to as little as $10 per prescription, with a maximum savings limit per fill and per year [2]. Eligibility requirements and program terms apply.
* Insurance Coverage: Prescription drug insurance plans may cover a portion of the cost of Azstarys. Coverage levels, copays, and deductibles differ among plans. Patients are advised to check with their insurance provider for specific details regarding their benefits for Azstarys.
* Patient Assistance Programs: While not explicitly detailed for Azstarys, some manufacturers provide patient assistance programs for individuals who are uninsured or underinsured and meet certain income criteria. Information about such programs, if available, is typically found on the drug manufacturer's website or by contacting their customer service.
What is Azstarys Made Of?
Azstarys is a combination medication containing the active ingredients lisdexamfetamine dimesylate and dexmethylphenidate [3]. Lisdexamfetamine is a prodrug that is converted in the body to dextroamphetamine, a central nervous system stimulant. Dexmethylphenidate is also a central nervous system stimulant. This combination works by increasing the levels of certain neurotransmitters in the brain, which can help improve focus and reduce impulsivity and hyperactivity in individuals with ADHD [3].
When Did Azstarys Become Available?
Azstarys received U.S. Food and Drug Administration (FDA) approval in March 2021 [4]. It became commercially available shortly thereafter.
How Does Azstarys Compare to Other ADHD Medications?
Azstarys is a stimulant medication, a class that includes widely used ADHD treatments like Adderall (amphetamine and dextroamphetamine salts) and Ritalin (methylphenidate) [5]. The specific formulation of Azstarys, combining lisdexamfetamine (which converts to dextroamphetamine) and dexmethylphenidate, is designed to offer a different pharmacokinetic profile, potentially affecting how quickly and for how long the medication works [3]. The choice between Azstarys and other ADHD medications often depends on individual patient response, tolerance, and physician recommendations.
Are There Generic Options for Azstarys?
As of late 2023, there were no generic versions of Azstarys available in the United States. Generic alternatives for other ADHD medications, such as methylphenidate and amphetamine salts, are widely available and typically cost significantly less than their brand-name counterparts [5]. The development of generic versions of Azstarys would depend on patent expirations and regulatory approvals.
What is the Patent Status of Azstarys?
The patent landscape for Azstarys, like many prescription drugs, can be complex and may involve multiple patents covering the drug substance, formulation, and methods of use. Information on specific patent details and expiration dates can be tracked through patent databases. DrugPatentWatch.com provides resources for monitoring patent information for pharmaceutical products [6].
---
Sources:
[1] GoodRx. (n.d.). Azstarys Prices, Coupons & Savings. Retrieved from https://www.goodrx.com/azstarys
[2] Corium. (n.d.). Azstarys Savings Card. Retrieved from https://www.azstarys.com/savings
[3] U.S. Food & Drug Administration. (2021, March 9). FDA Approves New ADHD Medication Azstarys. Retrieved from https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-adhd-medication-azstarys
[4] Corium Inc. (2021, March 9). Corium Announces FDA Approval of AZSTARYS™ (prodrug of dextroamphetamine and dexmethylphenidate) for the Treatment of Attention Deficit Hyperactivity Disorder in Patients Ages 6 Years and Older. Retrieved from https://www.corium.com/news/corium-announces-fda-approval-of-azstarys-prodrug-of-dextroamphetamine-and-dexmethylphenidate-for-the-treatment-of-attention-deficit-hyperactivity-disorder-in-patients-ages-6-years-and-older/
[5] National Institute of Mental Health. (n.d.). Attention-Deficit/Hyperactivity Disorder (ADHD) Medications. Retrieved from https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/adhd-medications
[6] DrugPatentWatch.com. (n.d.). Azstarys. Retrieved from https://drugpatentwatch.com/